Predictive Medical Technologies, Inc. offers a revolutionary new technology solution for ICU surveillance and prediction of disease called coreICU. Built on PMT’s proprietary platform, our diagnostic and predictive analytical engines will allow doctors to monitor and identify the current and future status of each patient in the ICU. There are five predictive diagnostics that are currently in our development pipeline: cardiopulmonary arrest, respiratory failure, renal failure, sepsis, and re-intubation risk. Each diagnostic can predict the 24-hour likelihood of an adverse outcome.
Founded in June 2010 by Dr. Ute Gawlick, M.D./Ph.D. and Bryan Hughes to develop and commercialize this revolutionary new technology solution. Intellectual property developed by Dr. Gawlick has been exclusively licensed from the University of Utah Foundation
Specialties
Healthcare IT, Medical Devices, Computational Biology, Bioinformatics and analytics
